Regulatory
LevelJump Announces Delay in Filing Annual Financial Statements
Regulatory Compliance Failure Threatens Liquidity as LevelJump Delays Annual Filings
Executive Summary
- On April 30, 2026, LevelJump Healthcare Corp. announced a delay in filing its annual financial statements and Management Discussion and Analysis (MD&A) for the fiscal period ending December 31, 2025.
- The company explicitly anticipates that a cease trade order will be issued by securities regulators due to this non-compliance.
- Management expects to complete and file the required documents by mid-May 2026.
- This announcement follows a private placement announced on April 7, 2026, which was expected to close around April 16, 2026, raising $750,000 for working capital.
Material Impact
- Regulatory Risk: The expectation of a cease trade order is a significant negative event. It halts trading, destroys liquidity, and signals severe internal control or accounting issues to the market.
- Contradiction with Financing: The company raised capital in early April 2026 at $0.05 per share under the assumption of regulatory compliance. Announcing a filing delay less than three weeks later undermines investor confidence in management's ability to meet obligations.
- Transparency Loss: Investors are left without audited annual financials for FY2025, making valuation impossible based on fundamental metrics until filed.
- Market Reaction: The stock price has already retreated from the $0.08 high seen in March/April 2026 to $0.06 by April 29, suggesting the market is pricing in increased risk prior to this specific announcement.
JUMP · Price
Company Overview
- Company: LevelJump Healthcare Corp. operates in the healthcare sector, specifically focusing on diagnostic imaging services.
- Flagship Project/Operations: The company derives revenue from outpatient clinics and teleradiology services. A key subsidiary is Canadian Teleradiology Services, which reported significant EBITDA contribution ($3.04M for nine months ended Sep 30, 2025).
- Development: Management has highlighted organic expansion plans including adding mammography, fluoroscopy, and pain-management services in Alberta. However, a planned acquisition of two Calgary clinics was terminated due to landlord approval issues.